Research/art/teacher profile of a person
Name and surname:
Mgr. Silvia Aziriová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Aziriova
I.2 - Name
Silvia
I.3 - Degrees
Mgr., PhD.
I.4 - Year of birth
1981
I.5 - Name of the workplace
Institute of fPahtological Physiology, Faculty of Medicine, Comenius University in Bratislava
I.6 - Address of the workplace
Špitálska 24, 813 72 Bratislava
I.7 - Position
Assistant Profesor
I.8 - E-mail address
silvia.aziriova@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/23407?do=filterForm-submit&surname=aziriov%C3%A1&sort=surname&employment_state=yes&filter=Vyh%C4%BEada%C5%A5
I.10 - Name of the study field in which a person works at the university
Pahological Physiology
I.11 - ORCID iD
https://orcid.org/0000-0002-1509-3794

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Philosophy, Comenius University in Bratislava
II.b - Year
2010
II.c - Study field and programme
Psychology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University
II.b - Year
2014
II.c - Study field and programme
Normal and Pathological Physiology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Assistant Profesor Faculty of Medicine 2014 - present

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Awarded Scientific - Qualification Level IIa Slovac Academy of Sciences 2019

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Pathological Physiology 1 + 2 in Slovak language General Medicine II General Medicine
Pathological Physiology 1 + 2 in Slovak language Dentistry II Dentistry
Pathological Physiology 1 in Slovak language Biomedical Physics II Biomedical Physics
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
4
V.4.c - Dissertation (third degree)
0
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
4
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
23
VI.1.b - Over the last six years
11
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
23
VI.1.b - Over the last six years
15
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
452
VI.1.b - Over the last six years
325
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
452
VI.1.b - Over the last six years
325
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

 Repova, K., Aziriova, S., Krajcirovicova, K., & Simko, F. (2022). Cardiovascular therapeutics: A new potential for anxiety treatment?. Medicinal research reviews, 42(3), 1202–1245. https://doi.org/10.1002/med.21875

2

Repova, K., Baka, T., Krajcirovicova, K., Stanko, P., Aziriova, S., Reiter, R. J., & Simko, F. (2022). Melatonin as a Potential Approach to Anxiety Treatment. International journal of molecular sciences, 23(24), 16187. https://doi.org/10.3390/ijms232416187

3

Repova, K., Aziriova, S., Kovacova, D., Trubacova, S., Baka, T., Kanska, R., Barta, A., Stanko, P., Zorad, S., Molcan, L., Adamcova, M., Paulis, L., & Simko, F. (2019). Lisinopril reverses behavioural alterations in spontaneously hypertensive rats. General physiology and biophysics, 38(3), 265 270. https://doi.org/10.4149/gpb_2019011

4

 Aziriova, S., Repova Bednarova, K., Krajcirovicova, K., Hrenak, J., Rajkovicova, R., Arendasova, K., Kamodyova, N., Celec, P., Zorad, S., Adamcova, M., Paulis, L., & Simko, F. (2014). Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril. Pharmacology, biochemistry, and behavior, 124, 284–289. https://doi.org/10.1016/j.pbb.2014.06.021

5

Krajcirovicova, K., Aziriova, S., Baka, T., Repova, K., Adamcova, M., Paulis, L., & Simko, F. (2018). Ivabradine does not impair anxiety-like behavior and memory in both healthy and L-NAME-induced hypertensive rats. Physiological research, 67(Suppl 4), S655–S664. https://doi.org/10.33549/physiolres.934048

VI.3 - The most significant research/artistic/other outputs over the last six years
1

 Repova, K., Aziriova, S., Krajcirovicova, K., & Simko, F. (2022). Cardiovascular therapeutics: A new potential for anxiety treatment?. Medicinal research reviews, 42(3), 1202–1245. https://doi.org/10.1002/med.21875

2

 Repova, K., Baka, T., Krajcirovicova, K., Stanko, P., Aziriova, S., Reiter, R. J., & Simko, F. (2022). Melatonin as a Potential Approach to Anxiety Treatment. International journal of molecular sciences, 23(24), 16187. https://doi.org/10.3390/ijms232416187

3

 Baka, T., Stanko, P., Repova, K., Aziriova, S., Krajcirovicova, K., Barta, A., Zorad, S., & Simko, F. (2023). Ivabradine curbs isoproterenol-induced kidney fibrosis. General physiology and biophysics, 42(2), 209–215. https://doi.org/10.4149/gpb_2022057

4

Repova, K., Stanko, P., Baka, T., Krajcirovicova, K., Aziriova, S., Hrenak, J., Barta, A., Zorad, S., Reiter, R. J., Adamcova, M., & Simko, F. (2022). Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril. Frontiers in pharmacology, 13, 978337. https://doi.org/10.3389/fphar.2022.978337

5

 Simko, F., Baka, T., Repova, K., Aziriova, S., Krajcirovicova, K., Paulis, L., & Adamcova, M. (2021). Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol-induced myocardial injury. Fundamental & clinical pharmacology, 35(4), 744–748. https://doi.org/10.1111/fcp.12620

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

 Aziriova, S., Repova Bednarova, K., Krajcirovicova, K., Hrenak, J., Rajkovicova, R., Arendasova, K., Kamodyova, N., Celec, P., Zorad, S., Adamcova, M., Paulis, L., & Simko, F. (2014). Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril. Pharmacology, biochemistry, and behavior, 124, 284–289. https://doi.org/10.1016/j.pbb.2014.06.021 Citované v: Liao, D., Shangguan, D., Wu, Y., Chen, Y., Liu, N., Tang, J., Yao, D., & Shi, Y. (2023). Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways. Psychopharmacology, 240(5), 1179–1190. https://doi.org/10.1007/s00213-023-06357-z

2

Aziriova, S., Repova Bednarova, K., Krajcirovicova, K., Hrenak, J., Rajkovicova, R., Arendasova, K., Kamodyova, N., Celec, P., Zorad, S., Adamcova, M., Paulis, L., & Simko, F. (2014). Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril. Pharmacology, biochemistry, and behavior, 124, 284–289. https://doi.org/10.1016/j.pbb.2014.06.021 Citované v: Kamińska, K., & Cudnoch-Jędrzejewska, A. (2023). A Review on the Neurotoxic Effects of Doxorubicin. Neurotoxicity research, 41(5), 383–397. https://doi.org/10.1007/s12640-023-00652-5

3

 Aziriova, S., Repova Bednarova, K., Krajcirovicova, K., Hrenak, J., Rajkovicova, R., Arendasova, K., Kamodyova, N., Celec, P., Zorad, S., Adamcova, M., Paulis, L., & Simko, F. (2014). Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril. Pharmacology, biochemistry, and behavior, 124, 284–289. https://doi.org/10.1016/j.pbb.2014.06.021 Citované v: Cardoso, C. V., de Barros, M. P., Bachi, A. L. L., Bernardi, M. M., Kirsten, T. B., de Fátima Monteiro Martins, M., Rocha, P. R. D., da Silva Rodrigues, P., & Bondan, E. F. (2020). Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration. Behavioural brain research, 378, 112233. https://doi.org/10.1016/j.bbr.2019.112233

4

 Aziriova, S., Repova Bednarova, K., Krajcirovicova, K., Hrenak, J., Rajkovicova, R., Arendasova, K., Kamodyova, N., Celec, P., Zorad, S., Adamcova, M., Paulis, L., & Simko, F. (2014). Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril. Pharmacology, biochemistry, and behavior, 124, 284–289. https://doi.org/10.1016/j.pbb.2014.06.021 Citované v: Ghaderi, A., Banafshe, H. R., Mirhosseini, N., Motmaen, M., Mehrzad, F., Bahmani, F., Aghadavod, E., Mansournia, M. A., Reiter, R. J., Karimi, M. A., & Asemi, Z. (2019). The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment. Addiction biology, 24(4), 754–764. https://doi.org/10.1111/adb.12650

5

 Aziriova, S., Repova Bednarova, K., Krajcirovicova, K., Hrenak, J., Rajkovicova, R., Arendasova, K., Kamodyova, N., Celec, P., Zorad, S., Adamcova, M., Paulis, L., & Simko, F. (2014). Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril. Pharmacology, biochemistry, and behavior, 124, 284–289. https://doi.org/10.1016/j.pbb.2014.06.021 Citované v: Cvikova, D., Sutovska, H., Babarikova, K., & Molcan, L. (2022). Hypotensive effects of melatonin in rats: Focus on the model, measurement, application, and main mechanisms. Hypertension research : official journal of the Japanese Society of Hypertension, 45(12), 1929–1944. https://doi.org/10.1038/s41440-022-01031-x

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

VEGA 1/0035/19 - Protection of the Cardiovascular System in Experimental Hypertension and Heart Failure via Dual Inhibition of Neprilysin and AT1 Receptors for Angiotensin II: Comparison with ACE Inhibition and Melatonin - Co-investigator, 2019-2022



2

VEGA 2/0112/19 - Experimental Myocardial Infarction: The Contribution of Hypertension and Obesity, Effect of Toll-like Receptor Inhibitor - Co-investigator, 2019-2022



3

APVV APVV-20-0421 - Cardiometabolic Effects of Mas Receptor Stimulation by Modulating the Renin-Angiotensin System - Co-investigator, 2019-2022



4

VEGA 1/0048/23 - Protection of the Cardiovascular System in Experimental Hypertension and Heart Failure by Inhibitor of Sodium-Glucose Cotransporter 2 – Dapagliflozin: Effects on the Heart, Vessels, and Kidneys. Comparison with ACE Inhibitor Captopril - Co-investigator, 2023-2025

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts